Real Chemistry

AI adoption in oncology is accelerating, but what does that look like in practice? At ESMO 2026, our e-Poster explores how oncologists are using GenAI and how large language models surface medical information. Sarah Frazer, Head of Medical Strategy, and Andrew Nelson, Senior Director, Integrated Intelligence, break down the findings that stood out to them, from widespread physician adoption to the growing need for multilingual patient communications. Dive deeper into the findings: https://lnkd.in/eURhtY53 And a special thanks to the rest of the incredible team behind this research: Heather Yvonne Rafferty, Katy Voorhorst, Lipi Kohli, Haley Brightman, Alicia Hayes, Mary Faith James, Lindsay Cardinal Murphy, Michelle Dunst, Celine Parmentier

Approval doesn’t always mean access. And for oncology launch teams, that gap is getting harder to ignore. As launch timelines become less predictable, the old playbook for sequencing, positioning and engagement strategy is being rewritten in real time. Ahead of ESMO, in our recent webinar with Fierce Pharma, we brought together industry experts to unpack what that means for oncology and launch teams, and how they’re adapting. Thank you to Brandon Fox, David Harland and Paolo Tarantino for sharing their perspectives, and to our Chief Medical Officer Ujwal Pyati, PhD for moderating the conversation. Watch the full discussion: https://lnkd.in/e4FQwYVz

AI may be a catalyst for transformation, but people are the ones who make it real. Amy Atwood, Head of Transformation, Change & Employee Experience with RC Resolve shares her principles for successful AI transformation with people at the center, including keeping humans at the helm, equipping managers to lead and making space for people to learn and adapt. Read more: https://lnkd.in/e_fBexB5

48 definitions later, asthma offers a lesson for COPD. As disease stability emerges as a potential treatment goal in COPD, asthma’s struggle to establish consistent remission definitions highlights an opportunity for medical affairs to help shape how treatment success is defined and measured. Our latest article looks at what pharma and medical affairs teams can do to build consensus and strengthen the evidence needed to move the field forward. Read more: https://lnkd.in/ex_fFY8x

Asia's role in shaping global healthcare innovation is growing fast. From breakthrough ideas and investment to the companies and partnerships bringing them to patients worldwide, the region is moving. At our From Market to Maker event in Singapore, we were joined by Amit Kakar, Leslie Chang, Ruth Kuguru and Carl Firth to explore what's driving Asia's rise as a healthcare innovation powerhouse and what could accelerate its global impact further still. The takeaway: Asia already has the innovation, ambition and momentum. The next opportunity is creating more pathways for regional success stories to travel further, faster. #HealthcareInnovation #AsiaPacific #APAC #Healthcare #LifeSciences

AI is trained on the past. What we create with it doesn’t have to be. Lauren Pollina, Executive Creative Director at 21GRAMS, part of Real Chemistry, explores what that means for the work we put into the world. If we use AI without recognizing its potential for bias, those biases don't disappear in the output. They show up in it. Read Lauren's full perspective: https://lnkd.in/g6zC8sXg